AEP vs NBIX · P/E 19, rev $21.88B vs P/E 45, rev $2.36B
American Electric Power Co Inc (AEP) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
American Electric Power Co Inc (AEP) is a utilities - regulated electric company listed on NASDAQ.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AEP revenue for 2025-12-31 was $21.88B. Net income was $3.70B. Revenue was up 9.5% from 2024-12-31 to 2025-12-31. AEP currently screens at market cap $69.79B and trailing P/E 19.0.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
AEP currently screens at market cap $69.79B and trailing P/E 19.0. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the AEP and NBIX stock pages for the full models.
Not investment advice.